Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals
Viruses · 2024
DOI: 10.3390/v16060852 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Jason S Chwa und 7 weiteren Autor:innen. Beteiligte Einrichtung: Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Immunoglobulin A, Secretory, Antibodies, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health (NIH).
Abstract (Originalsprache)
Mucosal immunity may contribute to clearing SARS-CoV-2 infection prior to systemic infection, thereby allowing hosts to remain seronegative. We describe the meaningful detection of SARS-CoV-2-specific nasal mucosal antibodies in a group of exposed-household individuals that evaded systemic infection. Between June 2020 and February 2023, nasopharyngeal swab (NPS) and acute and convalescent blood were collected from individuals exposed to a SARS-CoV-2-confirmed household member. Nasal secretory IgA (SIgA) antibodies targeting the SARS-CoV-2 spike protein were measured using a modified ELISA. Of the 36 exposed individuals without SARS-CoV-2 detected by the RT-PCR of NPS specimens and seronegative for SARS-CoV-2-specific IgG at enrollment and convalescence, 13 (36.1%) had positive SARS-CoV-2-specific SIgA levels detected in the nasal mucosa at enrollment. These individuals had significantly higher nasal SIgA (median 0.52 AU/mL) compared with never-exposed, never-infected controls (0.001 AU/mL) and infected-family participants (0.0002 AU/mL) during the acute visit, respectively (both p < 0.001). The nasal SARS-CoV-2-specific SIgA decreased rapidly over two weeks in the exposed seronegative individuals compared to a rise in SIgA in infected-family members. The nasal SARS-CoV-2-specific SIgA may have a protective role in preventing systemic infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, CA 90027, USA.
- Division of Infectious Diseases, Department of Pediatrics, University of California San Diego, San Diego, CA 92093, USA.
- Department of Pediatrics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
- Division of Infectious Diseases, Rady Children's Hospital, San Diego, CA 92123, USA.
ORCID-Profile: Jason S Chwa
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health (NIH)
Zitieren
APA
Chwa, J. S., Kim, M., Lee, Y., Cheng, W. A., Shin, Y., Jumarang, J., Bender, J. M., & Pannaraj, P. S. (2024). Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals. Viruses. https://doi.org/10.3390/v16060852
Vancouver
Chwa JS, Kim M, Lee Y, Cheng WA, Shin Y, Jumarang J, et al. Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals. Viruses. 2024. doi:10.3390/v16060852
BibTeX
@article{Chwa2024,
author = {Chwa, Jason S and Kim, Minjun and Lee, Yesun and Cheng, Wesley A and Shin, Yunho and Jumarang, Jaycee and Bender, Jeffrey M and Pannaraj, Pia S},
title = {Detection of SARS-CoV-2-Specific Secretory IgA and Neutralizing Antibodies in the Nasal Secretions of Exposed Seronegative Individuals},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16060852}
}
EUVIMED